|Systematic (IUPAC) name|
|CAS Registry Number|
|Molecular mass||400.50 g/mol|
AB-CHFUPYCA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2015. The pharmacological properties of this compound have not been formally studied or reported in the scientific literature, but its discovery in recreational drug products suggests that it is intended be a cannabinoid agonist. Although AB-CHFUPYCA contains structural elements common to the synthetic cannabinoid designer drugs AB-PINACA and AB-FUBINACA, it can also be considered an analog of the traditional pyrazole cannabinoid receptor 1 antagonist rimonabant.
- Uchiyama, N.; Asakawa, K.; Kikura-Hanajiri, R.; Tsutsumi, T.; Hakamatsuka, T. (2015). "A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products". Forensic Toxicology.